| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 32,677 | 32,263 | 30,610 | 28,447 | | Cost of Revenue | 11,866 | 11,412 | 10,830 | 11,594 | | | Gross Profit | 20,811 | 20,851 | 19,780 | 16,853 | | | Operating Expenses | | Research Development | 3,630 | 3,436 | 2,867 | 3,046 | | Selling General and Administrative | 17,788 | 18,373 | 18,747 | 17,828 | | Non Recurring | 50 | 4,493 | 1,290 | 150 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (657) | (5,451) | (3,124) | (4,171) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 295 | 182 | (227) | 499 | | Earnings Before Interest And Taxes | (362) | (5,269) | (3,351) | (3,672) | | Interest Expense | 923 | 918 | 916 | 1,161 | | Income Before Tax | (1,285) | (6,187) | (4,267) | (4,833) | | Income Tax Expense | (2) | 116 | 116 | 225 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (1,283) | (6,303) | (4,383) | (5,058) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (1,283) | (6,303) | (4,383) | (5,058) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($1,283) | ($6,303) | ($4,383) | ($5,058) |
|
0.00% Nasdaq 
0.09 (1.74%) 
Income Statement
